{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:06:10Z","timestamp":1773093970430,"version":"3.50.1"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1097\/pas.0000000000000272","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T12:38:41Z","timestamp":1403786321000},"page":"1468-1483","source":"Crossref","is-referenced-by-count":30,"title":["T-cell Prolymphocytic Leukemia Frequently Shows Cutaneous Involvement and Is Associated With Gains of MYC, Loss of ATM, and TCL1A Rearrangement"],"prefix":"10.1097","volume":"38","author":[{"given":"Andy C.","family":"Hsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane H.","family":"Robirds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike H.","family":"Kreisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Frater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TuDung T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":". Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1182\/blood-2012-07-440073","article-title":". Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases.","volume":"120","author":"Laurini","year":"2012","journal-title":"Blood"},{"key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood.V78.12.3269.3269","article-title":". Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia.","volume":"78","author":"Matutes","year":"1991","journal-title":"Blood"},{"key":"R4-3-20210131","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2004-01-0002","article-title":". A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories.","volume":"104","author":"Herling","year":"2004","journal-title":"Blood"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood-2012-01-380139","article-title":"How I treat prolymphocytic leukemia.","volume":"120","author":"Dearden","year":"2012","journal-title":"Blood"},{"key":"R6-3-20210131","first-page":"3S239","article-title":"T-cell prolymphocytic leukemia.","volume":"9suppl","author":"Dearden","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"R7-3-20210131","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(73)93135-8","article-title":". Prolymphocytic leukaemia of B and T cell type.","volume":"2","author":"Catovsky","year":"1973","journal-title":"Lancet"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1974.tb06769.x","article-title":". Prolymphocytic leukaemia.","volume":"27","author":"Galton","year":"1974","journal-title":"Br J Haematol"},{"key":"R9-3-20210131","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3816\/CLM.2005.n.051","article-title":". T-cell prolymphocytic leukemia: a single-institution experience.","volume":"6","author":"Ravandi","year":"2005","journal-title":"Clin Lymphoma Myeloma"},{"key":"R10-3-20210131","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0165-4608(03)00161-4","article-title":". High levels of chromosomal imbalances in typical and small-cell variants of T-cell prolymphocytic leukemia.","volume":"147","author":"Costa","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0165-4608(97)00410-X","article-title":". Abnormalities of chromosomes 8, 11, 14, and X in T- prolymphocytic leukemia studied by fluorescence in situ hybridization.","volume":"103","author":"Maljaei","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"R12-3-20210131","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1309\/KWJYBCCGTB90B6AE","article-title":"Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemialymphoma, and Sezary syndrome.","volume":"127","author":"Foucar","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R13-3-20210131","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaad.2006.04.060","article-title":". T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.","volume":"55","author":"Magro","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1309\/93P42RNG5XBG3KBE","article-title":". T-cell prolymphocytic leukemia involving extramedullary sites.","volume":"123","author":"Valbuena","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaad.2007.02.034","article-title":". Skin involvement in T-cell prolymphocytic leukemia.","volume":"57","author":"Herling","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R17-3-20210131","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jnen\/63.4.314","article-title":". Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.","volume":"63","author":"Fallon","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2141.1998.00977.x","article-title":". Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Francais dHematologie Cellulaire.","volume":"103","author":"Garand","year":"1998","journal-title":"Br J Haematol"},{"key":"R20-3-20210131","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1995.tb05023.x","article-title":". Cutaneous infiltration in T-cell prolymphocytic leukaemia.","volume":"132","author":"Mallett","year":"1995","journal-title":"Br J Dermatol"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000018423","article-title":"MM, Llopis Gonzalez A, Marquina Vila A, et al.. Mycosis fungoides: review of epidemiological observations.","volume":"201","year":"2000","journal-title":"Dermatology"},{"key":"R22-3-20210131","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clml.2012.06.010","article-title":"Age, race, sex, stage, and incidence of cutaneous lymphoma.","volume":"12","author":"Wilson","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood-2010-11-316794","article-title":". Type of skin eruption is an independent prognostic indicator for adult T-cell leukemialymphoma.","volume":"117","author":"Sawada","year":"2011","journal-title":"Blood"},{"key":"R24-3-20210131","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2133.2004.06274.x","article-title":". Clinicopathological features of cutaneous lesions of adult T-cell leukaemialymphoma.","volume":"152","author":"Yamaguchi","year":"2005","journal-title":"Br J Dermatol"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.pas.0000153121.57515.c6","article-title":". Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients.","volume":"29","author":"Massone","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R26-3-20210131","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":". WHO-EORTC classification for cutaneous lymphomas.","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/PAS.0b013e3182036ce7","article-title":". Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features.","volume":"35","author":"Pileri","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archdermatol.2010.101","article-title":". Folliculotropic mycosis fungoides: single-center study and systematic review.","volume":"146","author":"Lehman","year":"2010","journal-title":"Arch Dermatol"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1309\/YB79JG4TMJERQ7PV","article-title":". Primary Sezary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism.","volume":"123","author":"Diwan","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-0609.2008.01069.x","article-title":"Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper.","volume":"80","author":"Dungarwalla","year":"2008","journal-title":"Eur J Haematol"},{"key":"R31-3-20210131","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0145-2126(92)90168-7","article-title":". Phenotypic diversity and prognosis of adult T-cell leukemia.","volume":"16","author":"Kamihira","year":"1992","journal-title":"Leuk Res"},{"key":"R32-3-20210131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1309\/KEN4MXM5Y9A1GEMP","article-title":". Flow cytometric immunophenotyping of adult T-cell leukemialymphoma using CD3 gating.","volume":"124","author":"Yokote","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R33-3-20210131","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000323163","article-title":". Dual-positive (CD4CD8) acute adult T-cell leukemialymphoma associated with complex karyotype and refractory hypercalcemia: case report and literature review.","volume":"3","author":"Raza","year":"2010","journal-title":"Case Rep Oncol"},{"key":"R34-3-20210131","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/PAS.0000000000000109","article-title":". Clinicopathologic features of adult T-cell leukemiaslymphomas at a North American tertiary care medical center: infrequent involvement of the central nervous system.","volume":"38","author":"Hsi","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R35-3-20210131","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1097\/DAD.0b013e31823e25bb","article-title":". CD4CD8 dual-positive mycosis fungoides: a previously unrecognized variant.","volume":"34","author":"Knapp","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"R36-3-20210131","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/gcc.1141","article-title":". A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia.","volume":"31","author":"Soulier","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"R37-3-20210131","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00018-013-1426-x","article-title":"Polycomb group proteins and MYC: the cancer connection.","volume":"71","author":"Benetatos","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"R38-3-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MCB.19.1.1","article-title":"c-Myc target genes involved in cell growth, apoptosis, and metabolism.","volume":"19","author":"Dang","year":"1999","journal-title":"Mol Cell Biol"},{"key":"R39-3-20210131","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/sj.onc.1204595","article-title":"Translocations involving c-myc and c-myc function.","volume":"20","author":"Boxer","year":"2001","journal-title":"Oncogene"},{"key":"R40-3-20210131","first-page":"195","article-title":". Molecular mechanisms of a t(8;14)(q24;q11) translocation juxtaposing c-myc and TcR-alpha genes in a T-cell leukaemia: involvement of a V alpha internal heptamer.","volume":"2","author":"Bernard","year":"1988","journal-title":"Oncogene"},{"key":"R41-3-20210131","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1073\/pnas.95.7.3885","article-title":". Deregulated expression of TCL1 causes T cell leukemia in mice.","volume":"95","author":"Virgilio","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R42-3-20210131","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood.V87.5.1923.1923","article-title":". Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations.","volume":"87","author":"Madani","year":"1996","journal-title":"Blood"},{"key":"R43-3-20210131","first-page":"379","article-title":". Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.","volume":"12","author":"Thick","year":"1996","journal-title":"Oncogene"},{"key":"R44-3-20210131","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2007-07-101519","article-title":". High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.","volume":"111","author":"Herling","year":"2008","journal-title":"Blood"},{"key":"R45-3-20210131","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1309\/PNXUKA1CFJMVGCN1","article-title":". Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization.","volume":"130","author":"Feldman","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R46-3-20210131","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(00)00039-3","article-title":". The protooncogene TCL1 is an Akt kinase coactivator.","volume":"6","author":"Laine","year":"2000","journal-title":"Mol Cell"},{"key":"R47-3-20210131","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1096\/fj.06-7684com","article-title":". Proto-oncogene TCL1: more than just a coactivator for Akt.","volume":"21","author":"Noguchi","year":"2007","journal-title":"FASEB J"},{"key":"R48-3-20210131","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1182\/blood-2006-11-059501","article-title":". The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways.","volume":"110","author":"Despouy","year":"2007","journal-title":"Blood"},{"key":"R49-3-20210131","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/jcp.54.7.512","article-title":"Ataxia telangiectasia gene mutations in leukaemia and lymphoma.","volume":"54","author":"Boultwood","year":"2001","journal-title":"J Clin Pathol"},{"key":"R50-3-20210131","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1080\/1042819021000002884","article-title":". ATM mutations in sporadic lymphoid tumours.","volume":"43","author":"Stankovic","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"R51-3-20210131","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ng0997-96","article-title":". Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.","volume":"17","author":"Vorechovsky","year":"1997","journal-title":"Nat Genet"},{"key":"R52-3-20210131","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1182\/blood.V91.10.3920.3920_3920_3926","article-title":". Inactivation of the ATM gene in T-cell prolymphocytic leukemias.","volume":"91","author":"Stoppa-Lyonnet","year":"1998","journal-title":"Blood"},{"key":"R53-3-20210131","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1101\/gad.10.19.2401","article-title":"Dual roles of ATM in the cellular response to radiation and in cell growth control.","volume":"10","author":"Xu","year":"1996","journal-title":"Genes Dev"},{"key":"R54-3-20210131","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1097-1155","article-title":". Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.","volume":"3","author":"Stilgenbauer","year":"1997","journal-title":"Nat Med"},{"key":"R55-3-20210131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":". p53 mutations in human cancers.","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"R56-3-20210131","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2141.2000.02174.x","article-title":". p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sezary syndrome.","volume":"110","author":"Brito-Babapulle","year":"2000","journal-title":"Br J Haematol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:43:40Z","timestamp":1620967420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201411000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000272","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}